Advertisement

Topics

Certara adds externalization technology to its D360 scientific informatics platform

09:32 EDT 10 Aug 2017 | CentreWatch

Certara, a global provider of model-informed drug development and regulatory science, has added externalization technology to its D360 scientific informatics platform. The resulting new product, D360 Partner, facilitates collaboration between sponsors and their external research partners. Those external collaborators could include academic institutions, contract research organizations or third-party research groups. Those partners all have similar […]

The post Certara adds externalization technology to its D360 scientific informatics platform appeared first on CenterWatch News Online.

Original Article: Certara adds externalization technology to its D360 scientific informatics platform

NEXT ARTICLE

More From BioPortfolio on "Certara adds externalization technology to its D360 scientific informatics platform"

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...